Literature DB >> 19845484

Niosomes in sustained and targeted drug delivery: some recent advances.

Adnan Azeem1, Md Khalid Anwer, Sushama Talegaonkar.   

Abstract

Niosomes represent an emerging class of novel vesicular systems. They are composed of nonionic surfactants which are biodegradable and relatively nontoxic. They were developed as stable and inexpensive alternatives to liposomes. Since their early introduction to cosmetic industry their role has diversified to other application areas. They are now being ardently explored as potential carriers for sustained and targeted drug delivery. In addition to conventional, oral, and parenteral routes, they are amenable to be delivered by ocular, transdermal, vaginal, and inhalation routes. Delivery of biotechnological products including vaccine delivery with niosomes is also an interesting and promising research area. The introduction of provesicular approach in the form of proniosomes has further increased the relevance of these systems. More concerted research efforts, however, are still required to realize the full potential of these novel systems. This review considers the current status and explores the potential of niosomes in drug delivery with special attention to their role in drug targeting. Their methods of preparation, formulation aspects, advantages, limitations, and applications are also discussed.

Mesh:

Substances:

Year:  2009        PMID: 19845484     DOI: 10.3109/10611860903079454

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  13 in total

Review 1.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

2.  Investigation of formulation variables and excipient interaction on the production of niosomes.

Authors:  Zerrin Sezgin-Bayindir; Nilufer Yuksel
Journal:  AAPS PharmSciTech       Date:  2012-05-30       Impact factor: 3.246

3.  Quantiosomes as a multimodal nanocarrier for integrating bioimaging and Carboplatin delivery.

Authors:  Chwan-Fwu Lin; Chih-Jen Wen; Ibrahim A Aljuffali; Chun-Lin Huang; Jia-You Fang
Journal:  Pharm Res       Date:  2014-06-07       Impact factor: 4.200

4.  Venlafaxine HCl Encapsulated in Niosome: Green and Eco-friendly Formulation for the Management of Pain.

Authors:  Seyyed Mohammad Hassan Hashemi; Reza Enayatifard; Jafar Akbari; Majid Saeedi; Mohammad Seyedabadi; Katayoun Morteza-Semnani; Amirhossein Babaei; Kofi Asare-Addo; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2022-05-20       Impact factor: 3.246

5.  Potential Therapeutic Roles for Inhibition of the PI3K/Akt/mTOR Pathway in the Pathophysiology of Diabetic Retinopathy.

Authors:  Jorge L Jacot; David Sherris
Journal:  J Ophthalmol       Date:  2011-10-30       Impact factor: 1.909

6.  The inhibitory effect of Acyclovir loaded nano-niosomes against herpes simplex virus type-1 in cell culture.

Authors:  Seyed Hamidreza Monavari; Mohammad Javad Mirzaei Parsa; Bahram Bolouri; Soltan Ahmed Ebrahimi; Angila Ataei-Pirkooh
Journal:  Med J Islam Repub Iran       Date:  2014-09-17

Review 7.  Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy.

Authors:  Shivani Verma; Puneet Utreja
Journal:  Asian J Pharm Sci       Date:  2018-08-16       Impact factor: 6.598

8.  The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug.

Authors:  Morteza Yaghoobian; Azadeh Haeri; Noushin Bolourchian; Soraya Shahhosseni; Simin Dadashzadeh
Journal:  Int J Nanomedicine       Date:  2020-11-11

9.  Design and development of cefdinir niosomes for oral delivery.

Authors:  Saurabh Bansal; Geeta Aggarwal; Pankaj Chandel; S L Harikumar
Journal:  J Pharm Bioallied Sci       Date:  2013-10

10.  Polymeric microspheres as protein transduction reagents.

Authors:  David Nagel; Jonathan M Behrendt; Gwen F Chimonides; Elizabeth E Torr; Andrew Devitt; Andrew J Sutherland; Anna V Hine
Journal:  Mol Cell Proteomics       Date:  2014-04-01       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.